Triple negative breast cancer: A multi-omics network discovery strategy for candidate targets and driving pathways

Kubra Karagoz, Raghu Sinha, Kazim Yalcin Arga

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Triple negative breast cancer (TNBC) represents approximately 15% of breast cancers and is characterized by lack of expression of both estrogen receptor (ER) and progesterone receptor (PR), together with absence of human epidermal growth factor 2 (HER2). TNBC has attracted considerable attention due to its aggressiveness such as large tumor size, high proliferation rate, and metastasis. The absence of clinically efficient molecular targets is of great concern in treatment of patients with TNBC. In light of the complexity of TNBC, we applied a systematic and integrative transcriptomics and interactomics approach utilizing transcriptional regulatory and protein-protein interaction networks to discover putative transcriptional control mechanisms of TNBC. To this end, we identified TNBC-driven molecular pathways such as the Janus kinase-signal transducers, and activators of transcription (JAK-STAT) and tumor necrosis factor (TNF) signaling pathways. The multi-omics molecular target and biomarker discovery approach presented here can offer ways forward on novel diagnostics and potentially help to design personalized therapeutics for TNBC in the future.

Original languageEnglish (US)
Pages (from-to)115-130
Number of pages16
JournalOMICS A Journal of Integrative Biology
Volume19
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Triple Negative Breast Neoplasms
Janus Kinases
Biomarkers
Progesterone Receptors
Transcription
Epidermal Growth Factor
Estrogen Receptors
Tumors
Transducers
Proteins
Tumor Necrosis Factor-alpha
Protein Interaction Maps
Breast Neoplasms
Neoplasm Metastasis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

@article{c3174d25120b40ee9c5a3c31f967766d,
title = "Triple negative breast cancer: A multi-omics network discovery strategy for candidate targets and driving pathways",
abstract = "Triple negative breast cancer (TNBC) represents approximately 15{\%} of breast cancers and is characterized by lack of expression of both estrogen receptor (ER) and progesterone receptor (PR), together with absence of human epidermal growth factor 2 (HER2). TNBC has attracted considerable attention due to its aggressiveness such as large tumor size, high proliferation rate, and metastasis. The absence of clinically efficient molecular targets is of great concern in treatment of patients with TNBC. In light of the complexity of TNBC, we applied a systematic and integrative transcriptomics and interactomics approach utilizing transcriptional regulatory and protein-protein interaction networks to discover putative transcriptional control mechanisms of TNBC. To this end, we identified TNBC-driven molecular pathways such as the Janus kinase-signal transducers, and activators of transcription (JAK-STAT) and tumor necrosis factor (TNF) signaling pathways. The multi-omics molecular target and biomarker discovery approach presented here can offer ways forward on novel diagnostics and potentially help to design personalized therapeutics for TNBC in the future.",
author = "Kubra Karagoz and Raghu Sinha and Arga, {Kazim Yalcin}",
year = "2015",
month = "2",
day = "1",
doi = "10.1089/omi.2014.0135",
language = "English (US)",
volume = "19",
pages = "115--130",
journal = "OMICS A Journal of Integrative Biology",
issn = "1536-2310",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

Triple negative breast cancer : A multi-omics network discovery strategy for candidate targets and driving pathways. / Karagoz, Kubra; Sinha, Raghu; Arga, Kazim Yalcin.

In: OMICS A Journal of Integrative Biology, Vol. 19, No. 2, 01.02.2015, p. 115-130.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Triple negative breast cancer

T2 - A multi-omics network discovery strategy for candidate targets and driving pathways

AU - Karagoz, Kubra

AU - Sinha, Raghu

AU - Arga, Kazim Yalcin

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Triple negative breast cancer (TNBC) represents approximately 15% of breast cancers and is characterized by lack of expression of both estrogen receptor (ER) and progesterone receptor (PR), together with absence of human epidermal growth factor 2 (HER2). TNBC has attracted considerable attention due to its aggressiveness such as large tumor size, high proliferation rate, and metastasis. The absence of clinically efficient molecular targets is of great concern in treatment of patients with TNBC. In light of the complexity of TNBC, we applied a systematic and integrative transcriptomics and interactomics approach utilizing transcriptional regulatory and protein-protein interaction networks to discover putative transcriptional control mechanisms of TNBC. To this end, we identified TNBC-driven molecular pathways such as the Janus kinase-signal transducers, and activators of transcription (JAK-STAT) and tumor necrosis factor (TNF) signaling pathways. The multi-omics molecular target and biomarker discovery approach presented here can offer ways forward on novel diagnostics and potentially help to design personalized therapeutics for TNBC in the future.

AB - Triple negative breast cancer (TNBC) represents approximately 15% of breast cancers and is characterized by lack of expression of both estrogen receptor (ER) and progesterone receptor (PR), together with absence of human epidermal growth factor 2 (HER2). TNBC has attracted considerable attention due to its aggressiveness such as large tumor size, high proliferation rate, and metastasis. The absence of clinically efficient molecular targets is of great concern in treatment of patients with TNBC. In light of the complexity of TNBC, we applied a systematic and integrative transcriptomics and interactomics approach utilizing transcriptional regulatory and protein-protein interaction networks to discover putative transcriptional control mechanisms of TNBC. To this end, we identified TNBC-driven molecular pathways such as the Janus kinase-signal transducers, and activators of transcription (JAK-STAT) and tumor necrosis factor (TNF) signaling pathways. The multi-omics molecular target and biomarker discovery approach presented here can offer ways forward on novel diagnostics and potentially help to design personalized therapeutics for TNBC in the future.

UR - http://www.scopus.com/inward/record.url?scp=84923167998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923167998&partnerID=8YFLogxK

U2 - 10.1089/omi.2014.0135

DO - 10.1089/omi.2014.0135

M3 - Article

C2 - 25611337

AN - SCOPUS:84923167998

VL - 19

SP - 115

EP - 130

JO - OMICS A Journal of Integrative Biology

JF - OMICS A Journal of Integrative Biology

SN - 1536-2310

IS - 2

ER -